12:00 AM
 | 
Mar 12, 2012
 |  BC Week In Review  |  Company News  |  Deals

Avila, Celgene deal

Celgene completed its acquisition of Avila for $350 million in cash, plus up to $575 million in milestones. The milestones comprise up to...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >